In August, we published a hypothesis that since appears to have garnished the attention of the industry as evidenced by new studies and research. That hypothesis was that if our endogenous cannabinoid system (ECS) modules inflammation and if chronic inflammation is indeed a unifying theory of disease then it stands to reason that a well balanced and maintained ECS and lifestyle should lead to reduced inflammation. In turn, we may observe a reduction in those medical conditions said to be caused, or advanced, by inflammation.
Part of our hypothesis included the timing of two events – the illegality of cannabis and hemp soon followed by the change in our diet (from a keto type diet to the modern diet). Part of that hypothesis included the fact that two people as identical as two unrelated people can be (same health, medical condition, risk factors, etc) may have significantly differently results from the exact same strain of cannabis. As such, we predicted a rise of personal medicine (also known as genomics, pharmagenomics, etc).
Basically, a person’s DNA is used to map out the ideal medication and in our case the ideal cannabis strains and cannabinoid composition. Fast forward a few months and we find Aleafia investigating exactly that. The successful application of personalized medicine for cannabis to treat diabetes may be profound … ground-breaking.
Diabetics also know that accompanying the disease is often high cholesterol and blood pressure. The following recent headlines speak volumes and links are embedded for your convenience.
Cannabis researchers find breakthrough treatment for diabetes, high cholesterol
The key is a rare cannabinoid called THCV
How Cannabis oil can be used for diabetes treatment and prevention
Can Cannabis Treat, Or Even Prevent Diabetes?
Beneficial effects of a Cannabis sativa extract treatment on diabetes‐induced neuropathy and oxidative stress
A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study
CBD’s Effects on Cholesterol Levels
131